Your SlideShare is downloading. ×
  • Like
  • Save
The World Dermatological Market Outlook 2010-2024
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

The World Dermatological Market Outlook 2010-2024

  • 159 views
Published

Where will the main commercial opportunities lie in the treatment of skin disorders' Our new pharma market report explainsThe dermatological drug market continues to be important and competitive …

Where will the main commercial opportunities lie in the treatment of skin disorders' Our new pharma market report explainsThe dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasing disease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects of pharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The World Dermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developments will lie during our forecast period. And how you can benefit from this expansion.In particular, this study examines markets for treating the following skin disorders:' Dermatitis' Skin infections' Acne' Psoriasis.Also covered are the following dermatological conditions:' Alopecia' Rosacea.What types of therapeutic agent are likely to enter the market from 2010 onwards, and will they hold the potential to dominate this market area' Where will the best commercial opportunities in skin disorders lie from 2010 onwards' What are the most-crucial drivers and restraints in the global dermatological market' This report will provide you with the information that you need to understand current trends and future directions in pharmacological dermatology. In particular, we discuss commercial prospects for the following products in detail, from the present forward:' Medrol' Celestone' Protopic' Elocon' Aldara' Zovirax' Lamisil' Solodyn' Differin' BenzaClin' Diane' Daivobet' Taclonex' Dovonex' Propecia' Doryx' SurgicelComprehensive analysis of the global dermatology marketThe World Dermatological Market Outlook 2010-2024 critically examines that sector through a comprehensive review of primary and secondary information sources. Our new report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included, as well as two full interviews with relevant experts. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.Why you should buy The World Dermatological Market Outlook 2010-2024In this report, you will receive the following benefits in particular:' You will assess the current market for dermatological drugs' You will review the overall dermatological market, including a global sales forecast' You will receive sales forecasts for the main dermatological submarkets, with detailed discussions' You will receive sales forecasts for the leading products in those submarkets with discussions of market potential and competition' You will receive sales forecasts for leading geographical markets, with informed discussion' You will examine commercial drivers and restraints in depth' You will discover the most-exciting pipeline developments in the sector' You will discover expert opinions from our original interviews with authorities in industry and academia.You can obtain this report todayNobody with an interest in the dermatological market should overlook this new study. We predict that total revenues will increase during our forecast period, 2010 to 2024. With rising disease prevalence, expanding patient populations and clear unmet needs, this therapeutic area holds significant potential for further revenue growth and technological innovation. Do you want to harness those opportunities' You can stay ahead by ordering this report today.

Published in Business , Economy & Finance
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
159
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The World Dermatological Market Outlook 2010-2024Published on November 2009 Report SummaryWhere will the main commercial opportunities lie in the treatment of skin disorders Our new pharma market report explainsThe dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasingdisease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects ofpharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The WorldDermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developmentswill lie during our forecast period. And how you can benefit from this expansion.In particular, this study examines markets for treating the following skin disorders: Dermatitis Skin infections Acne Psoriasis.Also covered are the following dermatological conditions: Alopecia Rosacea.What types of therapeutic agent are likely to enter the market from 2010 onwards, and will they hold the potential to dominate thismarket area Where will the best commercial opportunities in skin disorders lie from 2010 onwards What are the most-crucial driversand restraints in the global dermatological market This report will provide you with the information that you need to understandcurrent trends and future directions in pharmacological dermatology. In particular, we discuss commercial prospects for the followingproducts in detail, from the present forward: Medrol Celestone Protopic Elocon Aldara Zovirax Lamisil Solodyn Differin BenzaClin Diane Daivobet Taclonex Dovonex Propecia DoryxThe World Dermatological Market Outlook 2010-2024 Page 1/12
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics SurgicelComprehensive analysis of the global dermatology marketThe World Dermatological Market Outlook 2010-2024 critically examines that sector through a comprehensive review of primary andsecondary information sources. Our new report provides detailed sales forecasts, market share analyses, discussions of pipelinedevelopments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figuresincluded, as well as two full interviews with relevant experts. The result is a comprehensive market- and industry-centred study, withdetailed analyses and informed opinion to benefit your work.Why you should buy The World Dermatological Market Outlook 2010-2024In this report, you will receive the following benefits in particular: You will assess the current market for dermatological drugs You will review the overall dermatological market, including a global sales forecast You will receive sales forecasts for the main dermatological submarkets, with detailed discussions You will receive sales forecasts for the leading products in those submarkets with discussions of market potential and competition You will receive sales forecasts for leading geographical markets, with informed discussion You will examine commercial drivers and restraints in depth You will discover the most-exciting pipeline developments in the sector You will discover expert opinions from our original interviews with authorities in industry and academia.You can obtain this report todayNobody with an interest in the dermatological market should overlook this new study. We predict that total revenues will increaseduring our forecast period, 2010 to 2024. With rising disease prevalence, expanding patient populations and clear unmet needs, thistherapeutic area holds significant potential for further revenue growth and technological innovation. Do you want to harness thoseopportunities You can stay ahead by ordering this report today. Table of ContentTable of ContentsChapter 1. Executive Summary1.1 Dermatological Market Review1.2 Aims, Scope and Format of the ReportChapter 2. An Introduction to Dermatological Diseases and Treatments2.1 An Introduction to Dermatology2.1.1 The Structure of the Skin2.1.2 Hair2.1.3 Nails2.1.4 Sweat and Serbacous Glands2.2.1 Protection2.2.2 SensationThe World Dermatological Market Outlook 2010-2024 Page 2/12
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics2.2.3 Vitamin D Synthesis2.2.4 Temperature Regulation and Heat Insulation2.2.5 Storage2.2.6 Prevention of Water Loss2.3 Common Skin Diseases2.4 An Introduction to Acne Vulgaris2.4.1 Acne Conglobata2.4.2 Acne Fulminans2.4.3 Gram-Negative Folliculitis2.4.4 Pyoderma Faciale2.4.5 Causes of Acne2.5 An Introduction to Dermatitis2.5.1 Atopic Dermatitis2.5.2 Contact Dermatitis2.5.3 Seborrheic Dermatitis2.5.4 Nummular Dermatitis2.5.5 Perioral Dermatitis2.6 An Introduction to Psoriasis2.6.1 Plaque Psoriasis2.6.2 Guttate Psoriasis2.6.3 Pustular Psoriasis2.6.4 Inverse Psoriasis2.6.5 Erythrodermic Psoriasis2.7 An Introduction to Rosacea2.7.1 Erythematotelangiectatic Rosacea2.7.2 Papulopustular Rosacea2.7.3 Phymatous Rosacea2.7.4 Ocular Rosacea2.8 An Introduction to Alopecia2.8.1 Alopecia Areata2.8.2 Alopecia Totalis2.8.3 Alopecia Universalis2.8.4 Androgenetic Alopecia2.8.5 Alopecia Barbae2.8.6 Alopecia Mucinosa2.8.7 Traction Alopecia2.8.8 Anagen Effluvium2.8.9 Telogen Effluvium2.9 An Introduction to Infectious Diseases of the Skin2.9.1 Bacterial Skin Infections2.9.1.1 Impetigo2.9.1.2 Folliculitis2.9.1.3 Cellulitis2.9.1.4 Furunculosis2.9.1.5 Carbuncle2.9.2 Fungal Skin Infections2.9.2.1 Tinea Pedis (Athletes Foot)2.9.2.2 Tinea Unguium (Ringworm of the Nails)2.9.2.3 Tinea Corporis (Ringworm of the skin)2.9.2.4 Tinea Capitis (Scalp Ringworm)The World Dermatological Market Outlook 2010-2024 Page 3/12
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics2.9.2.5 Kerions2.9.3 Viral Skin Infections2.9.3.1 Molluscum Contagiosum2.9.3.2 Warts2.9.3.3 Herpes Simplex2.9.3.4 Chickenpox2.9.3.5 Herpes Zoster2.10 Common Skin Treatments2.10.1 Creams and Semisolid Emulsions2.10.2 Ointments2.10.3 Lotions2.10.4 Solutions2.10.5 Occlusive Therapy2.10.6 Cleansing Agents2.10.7 Protecting Powders and Hydrophilic Polymer2.10.8 Anti-Infective Agents2.10.9 Anti-Inflammatory AgentsChapter 3. The World Dermatological Market, 2010-20243.1 The World Dermatological Market in 20093.2 The World Dermatological Market Forecast, 2010-20243.3 The Dermatitis Market Dominates the World Dermatological Market3.4 The Psoriasis Market Will Show the Highest Increase in Market Share3.5 Solodny is the Leading Drug in the Dermatological Market in 20093.6 Dermatological Blockbuster Drugs Will Be Increasingly Rare.3.7 The Future of the Dermatology Market3.8 The World Dermatology Market - OverviewChapter 4. The World Dermatitis Market, 2010-20244.1 The World Dermatitis Market in 20094.2 The World Dermatitis Market Analysis 2010-20244.3 Medrol (Methylprednisolone Acetate)4.3.1 Medrol Currently Leads the Dermatitis Market4.3.2 Will Medrol Lead the Dermatitis Market in 20244.4 Celestone (Betamethasone)4.4.1 Analysis of Forecast Celestone Sales 2009-20244.5 Protopic (Tacrolimus)4.5.1 Protopic Will Show an Early Increase in Revenues - But Will It Last4.6 Elocon (Mometasone Fuorate)4.6.1 Elocon Suffers From Generic Competition4.7 The World Dermatitis Market - SummaryChapter 5. The World Infectious Skin Diseases Market, 2010-20245.1 The World Infectious Skin Diseases Market in 20095.1.1 Topical Viral Infection Products Lead the Market in 20095.1.2 In 2009, Dermatological Antifungal Products Account for Half of Sales5.2 The World Infectious Skin Disease Market Forecast, 2010-20245.3 Aldara (Imiquimod)5.3.1 Aldara Leads the Infectious Skin Disease Market in 20095.3.2 Aldara Will Show An Early Increase in Revenues - But Will It LastThe World Dermatological Market Outlook 2010-2024 Page 4/12
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics5.4 Zovirax (Aciclovir)5.4.1 Analysis of Forecast Zovirax Sales 2009-20245.5 Lamisil (Terbinafine)5.5.1 Lamisil is the Leading Dermatological Antifungal Treatment in 20095.6 The World Infectious Skin Diseases Market - SummaryChapter 6. The World Acne Market, 2010 20246.1 The World Acne Market in 20096.1.1 Products Leading the Acne Market, 20096.2 The World Acne Market Forecast 2010-20246.3 Solodyn (Minocycline)6.3.1 Solodyn Currently Leads the World Acne Market6.3.2 Will Solodyn Sales Continue to Grow6.4 Differin (Adapalene)6.4.1 Sales Forecast for Differin, 2009-20246.4.2 Differin - Life Cycle Management6.5 BenzaClin (Benzoyl peroxide and Clindamycin)6.5.1 BenzaClin Sales Forecast Analysis 2009-20246.6 Diane6.6.1 Sales Forecast for Diane, 2009-20246.7 The World Acne Market - SummaryChapter 7. The World Psoriasis Market, 2010-20247.1 The World Psoriasis Market in 20097.1.1 Topical Antipsoriasis Treatments Lead the Psoriasis Market in 20097.2 The World Psoriasis Market Forecast 2010-20247.3 Daivobet (Calcipotriol & Betamethasone)7.3.1 Daivobet Leads the Psoriasis Market in 20097.3.2 Daivobet Will Benefit from the Removal of Raptiva from the Market7.4 Taclonex (Calcipotriol & Betamethasone)7.4.1 Sales Forecast for Taclonex, 2009-20247.5 Dovonex (Calcipotriol)7.5.1 Analysis of Dovonex Sales Forecast, 2009-20247.6 The World Psoriasis Market - SummaryChapter 8. The World Market for Miscellaneous Dermatological Drugs, 2010-20248.1 The Miscelleaneous Dermatological Drug Market in 20098.2 The Miscelleaneous Dermatological Drug Market Analysis, 2010-20248.3 Propecia (Finasteride)8.3.1 Revenues of Propecia Will Fall, 2009-20248.3.2 Other Alopecia Products8.4 Doryx (Doxycycline Hyclate)8.4.1 Forecast Sales of Doryx, 2009-20248.5 Surgicel8.5.1 Forecast Sales of Surgicel, 2009-20248.6 The Miscellaneous Market - SummaryChapter 9. Issues Affecting the Market for Dermatological Pharmaceuticals9.1 SWOT Analysis of the World Dermatological Market9.2 Market DriversThe World Dermatological Market Outlook 2010-2024 Page 5/12
  • 6. Find Industry reports, Company profilesReportLinker and Market Statistics9.3 Market Restraints9.4 There is Scope for Expansion into Related Markets9.5 Advances in Technology are Likely to Bring Benefits to the Market9.6 Consumer Bargaining Power9.7 Competition in the Dermatological Market Will Become Increasingly Intense9.8 Substitutes9.9 A Discussion of Generic Drugs in This Market - How Great is Their ThreatChapter 10. Dermatological Country Markets10.1 The Dermatological Market - Regional Breakdown10.2 Countries Leading the Dermatological Market, 200810.3 The Dermatological Market in the Nine Major Country Markets10.3.1 The Dermatological Market in the US10.3.2 The Dermatological Market in Japan10.3.3 The Dermatological Market in Germany10.3.4 The Dermatological Market in France10.3.5 The Dermatological Market in the UK10.3.6 The Dermatological Market in Italy10.3.7 The Dermatological Market in Spain10.3.8 The Dermatological Market in India10.3.9 The Dermatological Market in ChinaChapter 11. The Dermatological Pharmaceutical Pipeline11.1 The Potential of the Dermatological Market Has Encouraged R&D11.2 New Technology in Pipeline Developments11.2.1 Reformulation11.2.2 Combination Treatments11.2.3 New mechanisms11.2.4 Drug Delivery Technology11.3 Potential Entrants11.4 Pipeline Products in the Dermatitis Sector11.5 Pipeline Products in the Infectious Skin Disease Sector11.6 Pipeline Products in the Acne Sector11.7 Pipeline Products in the Psoriasis Sector11.8 Pipeline Products for Miscellaneous Dermatologicals11.9 Innovation Rules for Early-Stage PipelineDrugsChapter 12. Expert Views from Key Opinion Leaders12.1 Interview with the Product Development Director of a Pharmaceutical Company12.1.1 The Future of the Dermatology Market12.1.2 Areas Offering Growth Opportunities12.1.3 Future Development Trend12.1.4 Pipeline Products12.1.5 Unmet Needs in Dermatology12.1.6 Threats Facing the Dermatology Market12.2 Interview With Dr M.J.Thornton, BSc, PhD, Cutaneous Biology Group, University of Bradford.12.2.1 Androgen Based Science and Dermatology12.2.2 Key Areas For Dermatological Research12.2.3 Unmet Needs in Dermatology12.2.4 Future DevelopmentsThe World Dermatological Market Outlook 2010-2024 Page 6/12
  • 7. Find Industry reports, Company profilesReportLinker and Market Statistics12.2.5 Challenges in DermatologyChapter 13. Conclusions13.1 The World Dermatological Market Will Experience Gradual Financial Growth13.2 Market Drivers in the Dermatological Market13.3 Market Restraints in the Dermatological Market13.4 Will The Dermatitis Market Continue to Dominate the Dermatology Market13.5 The Skin Infection Market Faces Strong Generic Competition - Can it Expand13.6 Will the Acne Market Share Increase or Decline13.7 Will Growth of the Psoriasis Market Slow Down13.8 Why Growth in the Overall World Dermatological Market Will ContinueList of TablesTable 3.1 The World Dermatological Market Forecast, 2009-2016Table 3.2 The World Dermatological Market Forecast, 2017-2024Table 3.3 Leading Dermatological Markets Forecast, 2009-2016Table 3.4 Leading Dermatological Markets Forecast, 2017-2024Table 3.5 Market Shares of The Leading Dermatological Markets (%)Table 3.6 The Leading Drugs in the World Dermatological MarketTable 3.7 Leading Companies in the Dermatological MarketTable 4.1 Total Dermatitis Market Forecast, 2009-2016Table 4.2 Total Dermatitis Market Forecast, 2017-2024Table 4.3 The World Dermatitis Market Drugs Forecast, 2009-2016Table 4.4 The World Dermatitis Market Drugs Forecast, 2017-2024Table 4.5 Market Share of the Leading Dermatitis Drugs (%)Table 4.6 Leading Dermatitis Products Rank Comparison, 2009 and 2024Table 5.1 Total Infectious Skin Diseases Market Forecast, 2009-2016Table 5.2 Total Infectious Skin Diseases Market Forecast, 2017-2024Table 5.3 Sales of Skin Infection Products by Class (%), 2009Table 5.4 The World Infectious Skin Disease Market Drug Forecast, 2009-2016Table 5.5 The World Infectious Skin Disease Market Drug Forecast, 2017-2024Table 5.6 Market Share of the Leading Skin Infection Drugs (%)Table 5.7 Leading Skin Infection Products Rank Comparison, 2009 and 2024Table 6.1 Total Acne Market Forecast, 2009-2016Table 6.2 Total Acne Market Forecast, 2017-2024Table 6.3 The World Acne Market Drugs Forecast, 2009-2016Table 6.4 The World Acne Market Drugs Forecast, 2017-2024Table 6.5 Market Share of the Leading Acne Drugs (%)Table 6.6 Leading Acne Products Rank Comparison, 2009 and 2024Table 7.1 Total Psoriasis Market Forecast, 2009-2016Table 7.2 Total Psoriasis Market Forecast, 2017-2024Table 7.3 The World Psoriasis Market Drugs Forecast, 2009-2016Table 7.4 The World Psoriasis Market Drugs Forecast, 2017-2024Table 7.5 Market Share of the Leading Psoriasis Drugs (%)Table 7.6 Leading Psoriasis Products Rank Comparison, 2009 and 2024Table 8.1 Forecast of the Miscelleanous Market, 2009-2016Table 8.2 Forecast of the Miscelleanous Market, 2017-2024Table 8.3 World Market Forecast for Miscellaneous Dermatologicals ($m), 2008-2016Table 8.4 World Market Forecast for Miscellaneous Dermatologicals ($m), 2017-2024The World Dermatological Market Outlook 2010-2024 Page 7/12
  • 8. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 8.5 Market Share of the Leading Miscellaneous Drugs (%)Table 8.6 Leading Miscellanous Products Rank Comparison, 2009 and 2024Table 9.1 SWOT Analysis of the World Dermatological MarketTable 10.1 The Dermatological Market Revenues by Region ($m), 2008Table 10.2 Countries Leading the Dermatological Market, 2008Table 10.3 Dermatological Market Forecast for the Nine Major Country Markets, 2008-2016Table 10.4 Dermatological Market Forecast for the Nine Major Country Markets, 2017-2024Table 10.5 The Nine Major Country Markets - Market Share (%), 2009, 2014 & 2024Table 11.1 Key Pipeline Products for the Treatment of DermatitisTable 11.2 Key Pipeline Products for the Treatment of Infectious Skin DiseasesTable 11.3 Key Pipeline Products for the Treatment of AcneTable 11.4 Key Pipeline Products for the Treatment of PsoriasisTable 11.5 Key Pipeline Miscellaneous DermatologicalsList of FiguresFigure 3.1 World Dermatological Market Forecast ($m), 2009 - 2024Figure 3.2 The Leading Dermatological Markets Revenues ($m) 2009- 2024Figure 3.3 Market Share of the Leading dermatological Markets (%), 2009-2024Figure 3.4 The Leading Drugs in the World Dermatological Market, 2009Figure 4.1 World Dermatitis Market Sales ($m), 2009-2024Figure 4.2 Leading Dermatitis Drugs Forecast ($m), 2009-2024Figure 4.3 Market Share (%) of the Leading Dermatitis Products, 2009Figure 4.4 Market Share (%) of the Leading Dermatitis Products, 2014Figure 4.5 Market Share (%) of the Leading Dermatitis Products, 2024Figure 4.6 Medrol Sales Forecasts ($m), 2009-2024Figure 4.7 Celestone Sales Forecast ($m)Figure 4.8 Protopic Sales Forecast ($m), 2009-2024Figure 4.9 Elocon Sales Forecast ($m), 2009-2024Figure 5.1 World Infectious Skin Disease Market Revenues ($m), 2008- 2024Figure 5.2 Leading Infectious Skin Disease Drugs Forecast ($m), 2009- 2024Figure 5.3 Market Share (%) of the Leading Skin Infection Products, 2009Figure 5.4 Market Share (%) of the Leading Skin Infection Products, 2014Figure 5.5 Market Share (%) of the Leading Skin Infection Products, 2024Figure 5.6 Aldara Sales Forecasts ($m), 2009-2024Figure 5.7 Zovirax Sales Forecasts ($m), 2009-2024Figure 5.8 Lamisil Sales Forecasts ($m), 2009-2024Figure 6.1 World Acne Market Sales ($m), 2008-2024Figure 6.2 Leading Acne Drugs Forecast ($m), 2009-2024Figure 6.3 Market Share (%) of the Leading Acne Products, 2009Figure 6.4 Market Share (%) of the Leading Acne Products, 2014Figure 6.5 Market Share (%) of the Leading Acne Products, 2024Figure 6.6 Solodyn Sales Forecast ($m), 2009-2024Figure 6.7 Differin Sales Forecasts ($m), 2009-2024Figure 6.8 BenzaClin Sales Forecasts ($m), 2009-2024Figure 6.9 Diane Sales Forecasts ($m), 2009-2024Figure 7.1 World Psoriasis Market Sales ($m), 2009-2024Figure 7.2 Leading Psoriasis Drugs Forecast ($m), 2009-2024Figure 7.3 Market Share (%) of the Leading Psoriasis Products, 2009Figure 7.4 Market Share (%) of the Leading Psoriasis Products, 2014The World Dermatological Market Outlook 2010-2024 Page 8/12
  • 9. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 7.5 Market Share (%) of the Leading Psoriasis Products, 2024Figure 7.6 Daivobet Sales Forecasts ($m), 2009-2024Figure 7.7 Taclonex Sales Forecast ($m), 2009-2024Figure 7.8 Dovonex RSales Forecast ($m), 2009-2024Figure 8.1 World Market Forecast for Miscellaneous Dermatologicals ($m), 2009-2024Figure 8.2 Forecast for Leading Drugs in the Miscellaneous Dermatologicals Market ($m), 2009 -2024Figure 8.3 Market Share (%) of Leading Drugs in the Miscellaneous Dermatologicals Market, 2009Figure 8.4 Market Share (%) of Leading Drugs in the Miscellaneous Dermatologicals Market, 2014Figure 8.5 Market Share (%) of Leading Drugs in the Miscellaneous Dermatologicals Market, 2024Figure 8.6 Propecia Sales Forecast ($m) 2009-2024Figure 8.7 Doryx Sales Forecast ($m) 2009-2024Figure 8.8 Surgicel Sales Forecast ($m) 2009-2024Figure 10.1 Dermatological Market Revenues ($m) and Share (%) by RegionFigure 10.2 The 10 Countries Leading the Dermatological Market in 2008 - Revenues ($m)Figure 10.3 US and Japan Dermatological Market Forecasts, 2009-2024Figure 10.4 European, Indian and Chinese Dermatological Market Forecasts, 2009-2024Figure 10.5 Dermatological Market Share (%) by Country, 2009Figure 10.6 Dermatological Market Share (%) by Country, 2014Figure 10.7 Dermatological Market Share (%) by Country, 2024Companies ListedAbbottAlmirallAltanaAnacorAndroScienceAstellasAstionBarrBayerBayer ScheringCephalonCombinatoRxDr. Reddys LaboratoriesFerrerGaldermaGene Signal InternationalGlaxoSmithKlineGraceway PharmaceuticalsGruenenthalImpax Laboratories, IncIncyteIntercytexJohnson & JohnsonLOrealMaruhoMedicisMerck & Co.The World Dermatological Market Outlook 2010-2024 Page 9/12
  • 10. Find Industry reports, Company profilesReportLinker and Market StatisticsMedivirMinnesota 3MMoberg DermaMorriaMylan PharmaceuticalsNovartisNestle (Alcon, Galderma)OtsukaPfizerPola PharmaSanofi-AventisSchering-PloughShionogiStiefelTaishoTevaToyamaValeantWarner ChilcottXOMAThe World Dermatological Market Outlook 2010-2024 Page 10/12
  • 11. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. The World Dermatological Market Outlook 2010-2024 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 417.21 Quantity: _____ Department License--USD 4 834.42 Quantity: _____ Site License--USD 8 046.71 Quantity: _____ Corporate License--USD 11 265.95 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________The World Dermatological Market Outlook 2010-2024 Page 11/12
  • 12. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93The World Dermatological Market Outlook 2010-2024 Page 12/12